Pre- or postoperative radiotherapy for soft tissue sarcomas. 2020

C Llacer-Moscardo, and M Terlizzi, and S Bonvalot, and F Le Loarer, and S Carrère, and R Tetrau, and A D'ascoli, and D Lerouge, and C Le Péchoux, and J Thariat
Radiation Oncology Department, institut du cancer de Montpellier (ICM), 208, avenue des Apothicaires, parc Euromédecine, 34298 Montpellier cedex 5, France. Electronic address: carmen.llacer@icm.unicancer.fr.

Sarcomas are rare tumours arising from mesenchymal tissue. A multimodal management in an expert centre combining surgery and radiotherapy is the current standard of care for localized soft-tissue sarcomas of the extremities, to enable limb-sparing strategies. The delivery of pre- radiotherapy or postoperative radiotherapy offers similar local control and survival rates but the toxicity profile is quite different: preoperative radiotherapy increases the risk of wound complications and postoperative radiotherapy affects long-term functional outcomes. While postoperative radiotherapy has long been the rule, especially in Europe, technical improvements with image-guided- and intensity-modulated radiotherapy associated with a better management of postoperative wounds has tended to change practices with more frequent preoperative radiotherapy. More recently the possibilities of a hypofractionated regimen or potentiation by nanoparticles to increase the therapeutic index plead in favour of a preoperative delivery of radiotherapy. The aim of this paper is to report pros and cons of pre- and post-operative radiotherapy for soft-tissue sarcomas.

UI MeSH Term Description Entries
D011184 Postoperative Period The period following a surgical operation. Period, Postoperative,Periods, Postoperative,Postoperative Periods
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005121 Extremities The farthest or outermost projections of the body, such as the HAND and FOOT. Limbs,Extremity,Limb
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012509 Sarcoma A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant. Sarcoma, Epithelioid,Sarcoma, Soft Tissue,Sarcoma, Spindle Cell,Epithelioid Sarcoma,Epithelioid Sarcomas,Sarcomas,Sarcomas, Epithelioid,Sarcomas, Soft Tissue,Sarcomas, Spindle Cell,Soft Tissue Sarcoma,Soft Tissue Sarcomas,Spindle Cell Sarcoma,Spindle Cell Sarcomas
D012983 Soft Tissue Neoplasms Neoplasms of whatever cell type or origin, occurring in the extraskeletal connective tissue framework of the body including the organs of locomotion and their various component structures, such as nerves, blood vessels, lymphatics, etc. Neoplasm, Soft Tissue,Neoplasms, Soft Tissue,Soft Tissue Neoplasm
D057234 Preoperative Period The period before a surgical operation. Period, Preoperative

Related Publications

C Llacer-Moscardo, and M Terlizzi, and S Bonvalot, and F Le Loarer, and S Carrère, and R Tetrau, and A D'ascoli, and D Lerouge, and C Le Péchoux, and J Thariat
January 2014, Revue medicale de Liege,
C Llacer-Moscardo, and M Terlizzi, and S Bonvalot, and F Le Loarer, and S Carrère, and R Tetrau, and A D'ascoli, and D Lerouge, and C Le Péchoux, and J Thariat
February 1996, Journal of surgical oncology,
C Llacer-Moscardo, and M Terlizzi, and S Bonvalot, and F Le Loarer, and S Carrère, and R Tetrau, and A D'ascoli, and D Lerouge, and C Le Péchoux, and J Thariat
October 1990, International journal of radiation oncology, biology, physics,
C Llacer-Moscardo, and M Terlizzi, and S Bonvalot, and F Le Loarer, and S Carrère, and R Tetrau, and A D'ascoli, and D Lerouge, and C Le Péchoux, and J Thariat
November 2016, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],
C Llacer-Moscardo, and M Terlizzi, and S Bonvalot, and F Le Loarer, and S Carrère, and R Tetrau, and A D'ascoli, and D Lerouge, and C Le Péchoux, and J Thariat
October 1983, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen,
C Llacer-Moscardo, and M Terlizzi, and S Bonvalot, and F Le Loarer, and S Carrère, and R Tetrau, and A D'ascoli, and D Lerouge, and C Le Péchoux, and J Thariat
August 1998, Praxis,
C Llacer-Moscardo, and M Terlizzi, and S Bonvalot, and F Le Loarer, and S Carrère, and R Tetrau, and A D'ascoli, and D Lerouge, and C Le Péchoux, and J Thariat
November 1977, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen,
C Llacer-Moscardo, and M Terlizzi, and S Bonvalot, and F Le Loarer, and S Carrère, and R Tetrau, and A D'ascoli, and D Lerouge, and C Le Péchoux, and J Thariat
July 1963, JAMA,
C Llacer-Moscardo, and M Terlizzi, and S Bonvalot, and F Le Loarer, and S Carrère, and R Tetrau, and A D'ascoli, and D Lerouge, and C Le Péchoux, and J Thariat
November 2012, International journal of radiation oncology, biology, physics,
C Llacer-Moscardo, and M Terlizzi, and S Bonvalot, and F Le Loarer, and S Carrère, and R Tetrau, and A D'ascoli, and D Lerouge, and C Le Péchoux, and J Thariat
September 2023, Future oncology (London, England),
Copied contents to your clipboard!